Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02769520
Title Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ezra Cohen
Indications

laryngeal squamous cell carcinoma

hypopharynx cancer

oral squamous cell carcinoma

head and neck squamous cell carcinoma

oropharynx cancer

Therapies

Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.